发明名称 |
Once-a-day oxycodone formulations |
摘要 |
<p>Disclosed is a sustained release osmotic oral dosage form comprising: (a) a bilayer core comprising: (i) a drug layer comprising from about 1 mg to about 640 mg oxycodone or a pharmaceutically acceptable salt thereof; and (ii) a displacement layer comprising an osmopolymer; and (b) a semipermeable wall surrounding the bilayer core having a passageway disposed therein for the release of said oxycodone or pharmaceutically acceptable salt thereof; said dosage form providing an analgesic effect for at least about 24 hours and a mean C24/Cmax oxycodone ratio of 0.6 to 1.0 after once-a-day oral administration at steady state to human patients.</p> |
申请公布号 |
NZ529231(A) |
申请公布日期 |
2009.06.26 |
申请号 |
NZ20020529231 |
申请日期 |
2002.05.02 |
申请人 |
EURO-CELTIQUE S.A. |
发明人 |
OSHLACK, BENJAMIN;WRIGHT, CURTIS;PRATER, DEREK |
分类号 |
A61K9/00;A61K9/16;A61K9/20;A61K9/22;A61K9/24;A61K9/26;A61K9/30;A61K9/32;A61K9/36;A61K9/44;A61K9/48;A61K9/50;A61K9/52;A61K9/56;A61K31/485;A61P25/04 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|